Core Laboratories Inc. (CLB) Financial Statements
Core Laboratories Inc. (CLB) reported trailing twelve-month revenue of $519.2M (up 0.3% year on year) and net income of $24.4M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $10.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLBCore Laboratories Inc.Follow CLB — free
—
Price chart with a free account
- Market cap
- 454.7M
- P/E TTM
- 19.1
- Dividend yield
- 0.4%
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Revenue | 509.8 | 523.8 | 526.5 | 519.2 | |
| Gross profit | 109.8 | 103.3 | 108.9 | 101.3 | |
| Operating income | 54.6 | 58.6 | 56.5 | 47.8 | |
| Pre-tax income | 41.2 | 46.2 | 45.9 | 36.8 | |
| Income tax | 4.2 | 14.0 | 15.5 | 12.1 | |
| Net income | 36.7 | 31.4 | 29.7 | 24.4 | |
| Diluted EPS ($) | 0.77 | 0.66 | 0.63 | 0.52 | |
| Diluted shares (mn) | 47.5 | 47.7 | 47.0 | — |
USD millions · SEC XBRL
Core Laboratories Inc. — questions
- What is Core Laboratories Inc.'s revenue?
- $519.2M over the twelve months to 2026-06-30, up 0.3% year on year, from its 10-Q and 10-K filings.
- What is Core Laboratories Inc.'s net income?
- $24.4M over the twelve months to 2026-06-30.
- What is Core Laboratories Inc.'s free cash flow?
- $10.9M over the twelve months to 2026-06-30.
- What are Core Laboratories Inc.'s diluted earnings per share?
- $0.52 over the twelve months to 2026-06-30.
Every figure on this page comes from Core Laboratories Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.